MALKIEL BURTON G 4
4 · Theravance Biopharma, Inc. · Filed Aug 14, 2017
Insider Transaction Report
Form 4
MALKIEL BURTON G
Director
Transactions
- Purchase
Ordinary Shares
2017-08-11$24.59/sh+15,000$368,855→ 47,571 total - Purchase
Ordinary Shares
2017-08-11$24.59/sh+15,000$368,816→ 15,000 total(indirect: By Spouse)
Footnotes (2)
- [F1]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.35 to $24.921 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F2]Represents the weighted average purchase price per share for the open market purchase on August 11, 2017. The shares were purchased at prices ranging from $24.36 to $24.903 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.